Effect of an antimicrobial drug on lung microbiota in healthy dogs.

Alterations of the lung microbiota (LM) are associated with clinical features in chronic lung diseases (CLDs) with growing evidence that an altered LM contributes to the pathogenesis of such disorders. The common use of antimicrobial drugs in the management of CLDs likely represents a confounding factor in the study of the LM. The aim of the present study was to assess the effect of oral administration of amoxicillin/clavulanic acid (AC) on the LM in healthy dogs ( = 6) at short (immediately after stopping AC [D10]) and medium-term (16 days after stopping AC [D26]). Metagenetic analyses were performed on the V1-V3 hypervariable region of 16S rDNA after extraction of total bacterial DNA from samples of bronchoalveolar lavage fluid (BALF). AC did not induce significant changes in BALF cellular counts or in the bacterial load or microbial richness, evenness and α-diversity, while the β-diversity was clearly modified at D10 compared with D0 (before AC administration) and D26 ( < 0.01). The relative abundance of Bacteroidetes and Proteobacteria increased at D10 ( < 0.01) in comparison with D0 and D26 ( < 0.01). The relative abundance of Firmicutes decreased from D0 to D10 ( < 0.01) and increased from D10 to D26 ( < 0.01), but was still lower than at D0 ( < 0.01). The proportion of Actinobacteria increased at D26 compared with D0 and D10 ( < 0.01). Significant differences between timepoints at the level of family, genus or species were not found. In conclusion, in healthy dogs, oral administration of AC induces significant changes in LM at the phyla level and in the β-diversity. Most changes normalize within 2 weeks after discontinuation of AC.